ZURA logo

ZURA
Zura Bio Ltd - Ordinary Shares - Class A

1,096
Mkt Cap
$531.33M
Volume
500,372.00
52W High
$7.44
52W Low
$0.98
PE Ratio
-4.74
ZURA Fundamentals
Price
$5.65
Prev Close
$5.60
Open
$5.63
50D MA
$6.20
Beta
1.57
Avg. Volume
559,594.66
EPS (Annual)
-$1.06
P/B
4.10
Rev/Employee
$0.00
$383.99
Loading...
Loading...
News
all
press releases
Zura Bio (NASDAQ:ZURA) Shares Down 6.5% - Here's What Happened
Zura Bio (NASDAQ:ZURA) Shares Down 6.5% - Here's What Happened...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Zura Bio (ZURA) Projected to Post Quarterly Earnings on Wednesday
Zura Bio (NASDAQ:ZURA) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-1-zura-bio-limited-stock...
MarketBeat·17d ago
News Placeholder
Zura Bio (NASDAQ:ZURA) Price Target Raised to $11.00
Chardan Capital increased their price target on Zura Bio from $10.00 to $11.00 and gave the stock a "buy" rating in a report on Monday...
MarketBeat·19d ago
News Placeholder
Zura Bio (NASDAQ:ZURA) Given New $15.00 Price Target at Oppenheimer
Oppenheimer lowered their target price on shares of Zura Bio from $16.00 to $15.00 and set an "outperform" rating for the company in a research note on Friday...
MarketBeat·21d ago
News Placeholder
Zura Bio Limited (NASDAQ:ZURA) Given Average Recommendation of "Moderate Buy" by Analysts
Zura Bio Limited (NASDAQ:ZURA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the seven research firms that are currently covering the stock, Marketbeat Ratings...
MarketBeat·22d ago
News Placeholder
Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates
Zura Bio Limited (Nasdaq: ZURA) (Zura), a clinicalstage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating...
Business Wire·22d ago
News Placeholder
Boothbay Fund Management LLC Acquires New Shares in Zura Bio Limited $ZURA
Boothbay Fund Management LLC acquired a new position in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) during the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·25d ago
News Placeholder
Zura Bio Limited (NASDAQ:ZURA) Short Interest Up 16.2% in February
Zura Bio Limited (NASDAQ:ZURA - Get Free Report) was the recipient of a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling...
MarketBeat·25d ago
News Placeholder
Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress
Zura Bio Limited (Nasdaq: ZURA) (Zura), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and...
Business Wire·1mo ago
News Placeholder
Insider Buying: Zura Bio (NASDAQ:ZURA) Major Shareholder Purchases 2,000,000 Shares of Stock
Zura Bio Limited (NASDAQ:ZURA - Get Free Report) major shareholder Ai Biotechnology Llc bought 2,000,000 shares of the business's stock in a transaction on Thursday, February 26th. The stock was...
MarketBeat·1mo ago
<
1
2
...
>

Latest ZURA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.